These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9176026)

  • 1. HPLC glycosaminoglycan analysis in patients with Graves' disease.
    Hansen C; Fraiture B; Rouhi R; Otto E; Förster G; Kahaly G
    Clin Sci (Lond); 1997 May; 92(5):511-7. PubMed ID: 9176026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosaminoglycans in thyroid eye disease.
    Kahaly G; Förster G; Hansen C
    Thyroid; 1998 May; 8(5):429-32. PubMed ID: 9623737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary glycosaminoglycans in Graves' ophthalmopathy.
    Kahaly G; Schuler M; Sewell AC; Bernhard G; Beyer J; Krause U
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):35-44. PubMed ID: 2401097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sulfatation of orbital glycosaminoglycans in Graves' ophthalmopathy.
    Hansen C; Rouhi R; Förster G; Kahaly GJ
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1409-13. PubMed ID: 10199787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of human urinary hyaluronic acid, chondroitin sulphate and dermatan sulphate as their unsaturated disaccharides by high-performance liquid chromatography.
    Toyoda H; Motoki K; Tanikawa M; Shinomiya K; Akiyama H; Imanari T
    J Chromatogr; 1991 Apr; 565(1-2):141-8. PubMed ID: 1908476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The assessment of urinary glycosaminoglycans (GAG) excretion during therapy of patients with progressive Graves' ophthalmopathy].
    Pilarska K; Kulig G; Krzystolik Z
    Pol Arch Med Wewn; 2001 Feb; 105(2):139-44. PubMed ID: 11505748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.
    Komosinska-Vassev K; Blat D; Olczyk P; Szeremeta A; Jura-Półtorak A; Winsz-Szczotka K; Klimek K; Olczyk K
    Clin Biochem; 2014 Sep; 47(13-14):1341-3. PubMed ID: 24956269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.
    Satake S; Ototani N; Isemura M; Yosizawa Z
    Tohoku J Exp Med; 1983 May; 140(1):89-96. PubMed ID: 6408765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low sulfated glycosaminoglycans are excreted in patients with the Lowe syndrome.
    Kieras FJ; Houck GE; French JH; Wisniewski K
    Biochem Med; 1984 Apr; 31(2):201-10. PubMed ID: 6426474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydispersity of glycosaminoglycans in normal human urine.
    Endo M; Namiki O; Yosizawa Z
    Tohoku J Exp Med; 1980 Aug; 131(4):327-37. PubMed ID: 6781104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acidic glycosaminoglycans in human atherosclerotic cerebral arterial tissues.
    Murata K; Yokoyama Y
    Atherosclerosis; 1989 Jul; 78(1):69-79. PubMed ID: 2502994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The metabolism of glycosaminoglycans in the course of Graves' disease].
    Winsz-Szczotka K; Komosińska-Vassev K; Olczyk K
    Postepy Hig Med Dosw (Online); 2006; 60():184-91. PubMed ID: 16618989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in serum glycosaminoglycan profiles in Graves' patients.
    Komosińska-Vassev K; Winsz-Szczotka K; Olczyk K; Koźma EM
    Clin Chem Lab Med; 2006; 44(5):582-8. PubMed ID: 16681428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis.
    Wei DC; Politano VA; Selzer MG; Lokeshwar VB
    J Urol; 2000 May; 163(5):1577-83. PubMed ID: 10751891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and secretion of glycosaminoglycans in cultured retinal pigment epithelium.
    Stramm LE
    Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):618-27. PubMed ID: 3104227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hungatella hathewayi, an Efficient Glycosaminoglycan-Degrading
    Rawat PS; Li Y; Zhang W; Meng X; Liu W
    Appl Environ Microbiol; 2022 Nov; 88(22):e0154622. PubMed ID: 36342199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis.
    Akimoto S; Hayashi H; Ishikawa H
    Br J Dermatol; 1992 Jan; 126(1):29-34. PubMed ID: 1536759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fasting and time of day on the urinary excretion of chondroitin 4/6 sulphate, dermatan sulphate and four chondroitinase ABC resistant glycosaminoglycans.
    Poulsen JH; Gregersen H
    Scand J Clin Lab Invest; 1983 Dec; 43(8):665-70. PubMed ID: 6420878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distribution.
    Goulas A; Hatzichristou DG; Karakiulakis G; Mirtsou-Fidani V; Kalinderis A; Papakonstantinou E
    Prostate; 2000 Jul; 44(2):104-10. PubMed ID: 10881019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.